Study of Yavaksharadi Guti And Khadiradi Guti in Tundikeri(Tonsillitis).
Phase 1
- Conditions
- Health Condition 1: J039- Acute tonsillitis, unspecified
- Registration Number
- CTRI/2020/03/023810
- Lead Sponsor
- CARC Nigdi Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Patients presenting with two or more symptoms like Kathin Shotha, Todvat vedna, Ragatwa, Asyavairasya, Galoparodha as described in the context of Tundikeri.
2 Children of both genders.
3 Age group â?? 6 - 12 yrs.
Exclusion Criteria
Patients with peritonsilar abscess,tonsilar cyst, Tonsillolith will be excluded.
Patients with k/c/o HIV, TB.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate efficacy of Yavakshardi guti as per weight twice a day with Madhu is as effective as Khadiradi guti as per weight twice a day with Madhu in Tundikeri for 7 days.Timepoint: To evaluate efficacy of Yavakshardi guti as per weight twice a day with Madhu is as effective as Khadiradi guti as per weight twice a day with Madhu in Tundikeri for 7 days.
- Secondary Outcome Measures
Name Time Method To Study The Side Effects of Drug If Any.Timepoint: 7 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the anti-inflammatory effects of Yavaksharadi Guti and Khadiradi Guti in acute tonsillitis?
How do the efficacy outcomes of Yavaksharadi Guti and Khadiradi Guti compare to standard-of-care antibiotics for J039 tonsillitis?
Are there specific biomarkers associated with response to Yavaksharadi Guti and Khadiradi Guti in acute tonsillitis management?
What are the potential adverse events and safety management strategies for Yavaksharadi Guti and Khadiradi Guti in phase I trials?
What are the current combination therapies or competitor drugs for J039 tonsillitis in the context of CARC Nigdi Pune's research?